Company attributes
B2X
CEO
Founder
Date Incorporated
2005
Number of Employees (Ranges)
51 – 200
Email Address
info@kuurtx.com
Full Address
6200 Savoy Drive Suite 1200 Houston, TX 77036 USA
2617 Bissonnet Street Suite 300 Houston, TX 77005 United States
1 Canal Side Studios 8-14 Saint Pancras Way London, NW1 0QG United Kingdom
Investors
Founded Date
2005
Total Funding Amount (USD)
190,465,965
Latest Funding Round Date
March 2017
Glassdoor ID
Latest Funding Type
Patents Assigned (Count)
3
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
83,747,700
Previous Name
Cell Medica
Kuur Therapeutics (previously branded as Cell Medica) is a biotechnology company focusing on the development of cell therapies for cancer treatment. The company was founded in 2005 by Gregg Sando, and rebranded to Kuur Therapeutics in 2020. In 2021, Kuur Therapeutics was acquired by Athenix, Inc.
Timeline
No Timeline data yet.
